Is ADNRX or JNJ a better dividend investment in 2026?

ADNRX currently yields 10.70% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: ADNRX offers higher current income.

What is the dividend yield difference between ADNRX and JNJ?

ADNRX has a forward dividend yield of 10.70% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 7.34 percentage points.

Home › Compare › ADNRX vs JNJ

ADNRX vs JNJ: Dividend Comparison 2026

ADNRX yields 10.70% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ADNRX wins by $20.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

ADNRX

● Live price

10.70%

Share price

$18.70

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$40.6K

Annual income

$2,091.04

Full ADNRX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — ADNRX vs JNJ

📍 ADNRX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ADNRX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ADNRX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ADNRX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADNRX

Annual income on $10K today (after 15% tax)

$909.09/yr

After 10yr DRIP, annual income (after tax)

$1,777.38/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, ADNRX beats the other by $1,073.77/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADNRX + JNJ for your $10,000?

ADNRX: 50%JNJ: 50%

100% JNJ50/50100% ADNRX

Portfolio after 10yr

$30.3K

Annual income

$1,459.41/yr

Blended yield

4.82%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ADNRX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADNRX buys

JNJ buys

No recent congressional trades found for ADNRX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricADNRXJNJ

Forward yield	10.70% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$40.6K ✓	$20.0K
Annual income after 10y	$2,091.04 ✓	$827.78
Total dividends collected	$15.7K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ADNRX vs JNJ ($10,000, DRIP)

Year	ADNRX Portfolio	ADNRX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,770	$1,069.52	$10,676	$355.77	+$1.1K → ADNRX
2	$13,770	$1,176.42	$11,407	$389.39	+$2.4K → ADNRX
3	$16,020	$1,286.32	$12,198	$426.53	+$3.8K → ADNRX
4	$18,540	$1,398.62	$13,056	$467.62	+$5.5K → ADNRX
5	$21,351	$1,512.74	$13,987	$513.12	+$7.4K → ADNRX
6	$24,473	$1,628.09	$14,998	$563.56	+$9.5K → ADNRX
7	$27,930	$1,744.12	$16,098	$619.52	+$11.8K → ADNRX
8	$31,746	$1,860.29	$17,295	$681.69	+$14.5K → ADNRX
9	$35,944	$1,976.08	$18,599	$750.82	+$17.3K → ADNRX
10	$40,551	$2,091.04	$20,022	$827.78	+$20.5K → ADNRX

ADNRX vs JNJ: Complete Analysis 2026

ADNRX — Stock

Under normal circumstances, substantially all of the fund's assets are invested in a portfolio of equity securities including common stocks and other equity investments or ownership interests in business enterprises that are relevant to the fund's investment theme of transformational innovation. The fund's investments in foreign equity securities are principally in developed markets. It invests in American Depositary Receipts (''ADRs'') and securities sold on foreign exchanges and securities denominated in foreign currencies when purchasing foreign equities. The fund is non-diversified.

Full ADNRX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this ADNRX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADNRX vs SCHD ADNRX vs JEPI ADNRX vs O ADNRX vs KO ADNRX vs MAIN ADNRX vs ABBV ADNRX vs MRK ADNRX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.